Founded Date: 2011-01-01
Last Funding Type: Series B
Headquarters: Cambridge, Massachusetts, United States
Investors Number: 17.0
Technology: Biotechnology, Health Care, Medical
Employee Number: 11-50
Industry: End-to-End Drug Development
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-04-01
Funding Status: IPO
Total Funding: 249739241.0